| 1 |
Voelker R. What is ulcerative colitis?[J]. JAMA, 2024, 331(8):716.
|
| 2 |
Hodson R. Inflammatory bowel disease[J]. Nature, 2016, 540(7634): S97.
|
| 3 |
Martemucci G, Costagliola C, Mariano M, et al. Free radical properties, source and targets[J]. Antioxid Consumption Health Oxygen, 2022, 2(2): 48-78.
|
| 4 |
Juan CA, Pérez de la Lastra JM, Plou FJ, et al.The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies[J]. Int J Mol Sci, 2021, 22(9):4642.
|
| 5 |
Nakase H, Sato N, Mizuno N, et al. The influence of cytokines on the complex pathology of ulcerative colitis[J]. Autoimmun Rev, 2022, 21(3): 103017.
|
| 6 |
Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents[J]. Nat Rev Mol Cell Biol, 2020, 21(7): 363-383.
|
| 7 |
Kushkevych I, Martinkova K, Vitezova M, et al. Intestinal microbiota and perspectives of the use of meta-analysis for comparison of ulcerative colitis studies [J]. J Clin Med, 2021, 10(3): 462.
|
| 8 |
Carini F, Mazzola M, Rappa F, et al. Colorectal carcinogenesis: role of oxidative stress and antioxidants[J]. Anticancer Res, 2017, 37(9): 4759-4766．
|
| 9 |
Tian T, Wang Z, Zhang J. Pathomechanisms of oxidative stress in inflammatory bowel disease and potential antioxidant therapies[J].Oxid Med Cell Longev, 2017, 2017: 4535194.
|
| 10 |
Reynolds JM, Angkasekwinai P, Dong C.IL-17 family member cytokines: regulation and function in innate immunity[J]. Cytokine Growth Factor Rev, 2010, 21(6): 413-423.
|
| 11 |
Arisawa T, Tahara T, Shibata T, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis[J]. J Clin Immunol, 2008, 28(1): 44-49.
|
| 12 |
Kim SW, Kim ES, Moon CM, et al. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease[J]. Gut, 2011, 60(11): 1527-1536.
|
| 13 |
Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system[J]. Nat Rev Immunol, 2010, 10(7): 479-489.
|
| 14 |
Ohman L, Dahlén R, Isaksson S, et al. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of diseas[J]. Inflamm Bowel Dis, 2013, 19(11): 2433-2439.
|
| 15 |
Ajdukovi J, Tonki A, Salamuni I, et al. Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis[J].Hepatogastroenterology，2010, 57(104):1442-1444.
|
| 16 |
Yu P, Shen F, Zhang X, et al. Association of single nucleotide polymorphisms of IL23R and IL17 with ulcerative colitis risk in a Chinese Han population[J].PLoS One，2012,7(9):e44380.
|
| 17 |
Hyun YS, Han DS, Lee AR,et al. Role of IL-17A in the development of colitis-associated cancer[J].Carcinogenesis，2012，33(4):931-936.
|
| 18 |
Bingham CO. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation[J]. J Rheumatol Suppl, 2002, 65:3-9.
|
| 19 |
Ljung T, Herulf M, Beijer E, et al. Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection[J]. Scand J Gastroenterol, 2001, 36(10): 1073-1076.
|
| 20 |
Guihot G, Guimbaud R, Bertrand V, et al. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn’s disease[J].Amino Acids, 2000, 18(3): 229-237.
|
| 21 |
Perner A, Andresen L, Normark M, et al. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis[J]. Gut，2001, 49(3): 387-394.
|
| 22 |
Dijkstra G, Zandvoort AJ, Kobold AC, et al. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease[J].Scand J Gastroenterol, 2002, (5): 546–554.
|
| 23 |
Colón AL, Menchén LA, Hurtado O, et al. Implication of TNF-alpha convertase (TACE/ADAM17) in inducible nitric oxide synthase expression and inflammation in an experimental model of colitis[J].Cytokine, 2001, 16(6): 220-226.
|
| 24 |
张可,邓长生,朱尤庆,等. 核因子-κB、环氧化酶-2和诱导型一氧化氮合酶在溃疡性结肠炎组织中的表达意义[J]. 世界华人消化杂志, 2002, 10(5):575-578.
|
| 25 |
Goodstone NJ, Hardingham TE.Tumour necrosis factor alpha stimulates nitric oxide production more potently than interleukin-1beta in porcine articular chondrocytes[J]. Rheumatology(Oxford), 2002, 41(8): 883-891.
|
| 26 |
Hoffmann U, Heilmann K, Hayford C, et al. CD44v7 ligation downregulates the inflammatory immune response in Crohn’s disease patients by apoptosis induction in mononuclear cells from the lamina propria[J]. Cell Death Differ, 2007, 14(8): 1542-1551．
|
| 27 |
Brazil JC, Lee WY, Kolegraff KN, et al. Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface[J]. J Immunol, 2010, 185(11):7026-7036.
|
| 28 |
Song X. Efcient therapy of infammatory bowel disease (IBD) with highly specifc and durable targeted Ta(2)C modifed with chondroitin sulfate (TACS)[J]. Adv Mater, 2023, 35(36): e2301585.
|
| 29 |
Franić I. Expression of CD44 in leukocyte subpopulations in patients with infammatory bowel diseases[J]. Diagnostics (Basel)，2014, 12(8):2022.
|
| 30 |
Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor[J].J Immunol, 1995,155(5):2587-2594.
|
| 31 |
Hartl D, Latzin P, Hordijk P, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease[J]. Nat Med, 2007, 13(12): 1423-1430.
|
| 32 |
Samie A, Dzhivhuho GA, Nangammbi TC. Distribution of CXCR2 +1208 T/C gene polymorphisms in relation to opportunistic infections among HIV-infected patients in Limpopo Province, South Africa[J]. Genet Mol Res, 2014, 13(3): 7470-7479.
|
| 33 |
Craig A, Mai J, Cai S, et al.Neutrophil recruitment to the lungs during bacterial pneumonia[J]. Infect Immun, 2009, 77(2): 568-575.
|
| 34 |
Heidarian F, Alebouyeh M, Shahrokh S, et al. Altered fecal bacterial composition correlates with disease activity in inflammatory bowel disease and the extent of IL8 induction[J]. Curr Res Transl Med, 2019, 67(2): 41-50.
|
| 35 |
Cao F, Cheng YS, Yu L, et al.Bioinformatics analysis of differentially expressed genes and protein-protein raction networks associated with functional pathways in ulcerative colitis[J]. Inte Med Sci Monit, 2021, 19(27):1-11.
|
| 36 |
Semenza GL. Targeting HIF-1 for cancer therapy[J]. Nat Rev Cancer, 2003, 3(10): 721-732.
|
| 37 |
Giatromanolaki A, Sivridis E, Maltezos E, et al. Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease[J].J Clin Pathol, 2003, 56(3): 209-213.
|
| 38 |
Yin J, Ren Y, ang K, et al.The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease[J]. Cell Biol Int, 2022, 46(1): 46-51.
|
| 39 |
Pral LP, Fachi JL, Corrêa RO, et al. Hypoxia and HIF-1 as key regulators of gut microbiota and host interactions[J]. Trends Immunol, 2021, 42(7): 604-621.
|
| 40 |
Cao W, Vrees MD, Potenti FM, et al.Interleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitis[J]. J Pharmacol Exp Ther, 2004, 311(1): 60-70.
|
| 41 |
Li DF, Chang X, Zhao JL, et al.Colonic epithelial PHLPP2 deficiency promotes colonic epithelial pyroptosis by activating the NF-κB signaling pathway[J]. Oxid Med Cell Longev, 2021, 2021: 5570731.
|
| 42 |
Mitsialis V, Wall S, Liu P, et al.Single-cell analyses of colon and blood reveal distinct immune cell signatures of ulcerative colitis and Crohn’s disease[J].Gastroenterology, 2020,159(2):591-608.
|
| 43 |
Zhang B, Chen H, Ouyang J, et al. SQSTM1-dependent autophagic degradation of PKM2 inhibits the production of mature IL1B/IL-1β and contributes to LIPUS-mediated anti-inflammatory effect[J].Autophagy, 2020, 16(7): 1262-1278.
|
| 44 |
Bulek K, Zhao J, Liao Y, et al. Epithelial-derived gasdermin D mediates nonlytic IL-1β release during experimental colitis[J]. J Clin Invest, 2020, 130(8): 4218-4234.
|
| 45 |
Lippai R, Veres-Székely A, Sziksz E, et al. Immunomodulatory role of Parkinson’s disease 7 in inflammatory bowel disease[J].Sci Rep, 2021, 11(1): 14582.
|
| 46 |
Sendler M, van den Brandt C, Glaubitz J, et al. NLRP3 inflammasome regulates development of systemic inflammatory response and compensatory anti-inflammatory response syndromes in mice with acute pancreatitis[J]. Gastroenterology, 2020, 158(1): 253-269.
|
| 47 |
Rangaraju S, Dammer EB, Raza SA, et al.Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease[J]. Mol Neurodegener, 2018, 13(1): 24.
|
| 48 |
Rawat M, Nighot M, Al-Sadi R, et al. IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA[J]. Gastroenterology, 2020, 159(4): 1375-1389.
|
| 49 |
Tedeschi V, Secondo A. Emerging role of lysosomal calcium store as a hub of neuroprotection[J]. Neural Regen Res, 2022, 17(6): 1259-1260.
|
| 50 |
Kong Y, Zhao X, Qiu M, et al. Tubular Mas receptor mediates lipid-induced kidney injury[J]. Cell Death Disease, 2021, 12(1): 110.
|
| 51 |
Salazar G, Cullen A, Huang J, et al. SQSTM1/p62 and PPARGC1A/PGC-1alpha at the interface of autophagy and vascular senescence[J].Autophagy, 2020, 16(6): 1092-1110.
|
| 52 |
Shen L, Zhang T, Lu H. Overexpression of AGT promotes bronchopulmonary dysplasis via the JAK/STAT signal pathway[J]. Oncotarget, 2017, 8(56): 9607996088.
|